Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 4813 record(s)

Req # A-2020-000590

Adverse Reaction Reports (AERs). Report numbers: E2B_02333453, E2B_02386606, E2B_02396230, E2B_02706721, E2B_02429349, E2B_02713262, E2B_02841240, E2B_02859828, E2B_02923267, E2B_02891035, E2B_02888013, E2B_03006384, E2B_02980722.

Organization: Health Canada

253 page(s)
April 2021

Req # A-2020-000591

Adverse Reaction Reports (AERs). Report numbers: E2B_02881363, 000730668, E2B_02591899, E2B_01740867, E2B_01788978, E2B_01835989, 000714223, E2B_01899768, E2B_01948249, E2B_01992536, E2B_01951261.

Organization: Health Canada

232 page(s)
April 2021

Req # A-2020-000621

Adverse Reaction Reports (AERs). Report numbers: E2B_03090183, E2B_03092784.

Organization: Health Canada

25 page(s)
April 2021

Req # A-2020-000674

Adverse Reaction Reports (AERs) for FLUDARABINE PHOSPHATE. Report numbers: 000736281, 000736290.

Organization: Health Canada

17 page(s)
April 2021

Req # A-2020-000738

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_02690598.

Organization: Health Canada

9 page(s)
April 2021

Req # A-2020-000741

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03181965.

Organization: Health Canada

6 page(s)
April 2021

Req # A-2020-000813

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03170851.

Organization: Health Canada

20 page(s)
April 2021

Req # A-2020-000879

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-106577-364, Deputy Ministerial meeting with Genome Canada.

Organization: Health Canada

4 page(s)
April 2021

Req # A-2020-000929

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111425-907.

Organization: Health Canada

13 page(s)
April 2021

Req # A-2020-000968

Adverse Reaction Reports (AERs). Report numbers: E2B_01678513, E2B_03248420, E2B_02121844, E2B_03233687, E2B_03233686, E2B_03234927, E2B_03234929.

Organization: Health Canada

175 page(s)
April 2021
Date modified: